港股異動 | 滔搏跌超6%續創新低 7日連跌近30% 遭機構唱空
格隆匯10月31日丨滔搏(6110.HK)延續跌勢,再度下跌超6%,7日連跌近30%,盤中低見3.88港元創歷史新低,總市值跌破250億港元。公司日前公佈中期淨利11.45億元,同比下降19.9%。瑞信下調滔搏目標價至5港元,將2023至2024財年每股盈利預測降低21%至24%。維持“中性”評級;麥格理考慮滔博線下人流恢復較預期慢,加上內地持續的防疫限制,下調其銷售展望,並將其2023及2024財年盈利預測下調各13%,股份目標價由8.5港元降至7.8港元,評級維持“跑贏大市”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.